FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211804865> ?p ?o ?g. }

• W3211804865 abstract "Prostate cancer (PCa) endangers the life and health of older men. Most PCa cases develop into castration‑resistant PCa (CRPC) within 2 years. At present, the molecular mechanisms of the occurrence and development of PCa and its transformation to CRPC remain unknown. The present study aimed to investigate the role of CKLF‑like Marvel transmembrane domain containing family member 5 (CMTM5) in PCa and its molecular mechanism in vitro. PCa tissues and paired adjacent normal prostate tissues from 70 patients were collected to examine the expression levels of CMTM5 and EGFR via immunohistochemistry, reverse transcription‑quantitative PCR and western blotting. Then, CMTM5‑overexpressing DU145 cells were constructed, and CMTM5 expression in these transfected cells and vector control cells was examined via western blotting. Cell Counting Kit‑8 and plate clone formation assays were used to evaluate the proliferation and colony number of CMTM5‑overexpressing cells and vector control cells. Then, cell migration and invasion were assessed using wound healing assay, Transwell assay and immunofluorescence analysis with DAPI staining. The effect of CMTM5 on apoptosis and its underlying molecular mechanism were examined using western blotting and flow cytometry. The results demonstrated that CMTM5 expression in PCa tissues and cell lines was significantly downregulated, while EFGR expression was significantly upregulated. The proportion of high CMTM5 expression in PCa tissues was significantly lower compared with that in normal prostate tissues. By contrast, the proportion of high EGFR expression in PCa tissues was significantly increased compared with that in normal prostate tissues. Moreover, CMTM5 overexpression significantly inhibited cell proliferation, migration and invasion, and promoted cell apoptosis compared with vector control cells in vitro. Furthermore, the regulation of PCa by CMTM5 was associated with the downregulation of PI3K/AKT and its downstream Bcl‑2 expression, as well as the upregulation of Bax expression. In conclusion, CMTM5 may be an effective tumor suppressor gene for PCa, especially for castration‑resistant PCa, by downregulating EGFR and PI3K/AKT signaling pathway components." @default.
• W3211804865 created "2021-11-22" @default.
• W3211804865 creator A5002294781 @default.
• W3211804865 creator A5007923055 @default.
• W3211804865 creator A5022810915 @default.
• W3211804865 creator A5025224262 @default.
• W3211804865 creator A5043860673 @default.
• W3211804865 creator A5057022966 @default.
• W3211804865 creator A5059859222 @default.
• W3211804865 creator A5060097504 @default.
• W3211804865 creator A5065196461 @default.
• W3211804865 date "2021-11-15" @default.
• W3211804865 modified "2023-10-18" @default.
• W3211804865 title "CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway" @default.
• W3211804865 cites W1914427426 @default.
• W3211804865 cites W1982114820 @default.
• W3211804865 cites W1992521009 @default.
• W3211804865 cites W1994687075 @default.
• W3211804865 cites W1998450591 @default.
• W3211804865 cites W2017057328 @default.
• W3211804865 cites W2030500039 @default.
• W3211804865 cites W2048478533 @default.
• W3211804865 cites W2055318932 @default.
• W3211804865 cites W2078050621 @default.
• W3211804865 cites W2096279781 @default.
• W3211804865 cites W2096909126 @default.
• W3211804865 cites W2107277218 @default.
• W3211804865 cites W2120346211 @default.
• W3211804865 cites W2120735394 @default.
• W3211804865 cites W2157894482 @default.
• W3211804865 cites W2192080449 @default.
• W3211804865 cites W2238627408 @default.
• W3211804865 cites W2267459829 @default.
• W3211804865 cites W2328671688 @default.
• W3211804865 cites W2343575524 @default.
• W3211804865 cites W2510435007 @default.
• W3211804865 cites W2555562157 @default.
• W3211804865 cites W2590318769 @default.
• W3211804865 cites W2624356668 @default.
• W3211804865 cites W2753157341 @default.
• W3211804865 cites W2787401717 @default.
• W3211804865 cites W2802584009 @default.
• W3211804865 cites W2810567215 @default.
• W3211804865 cites W2893912995 @default.
• W3211804865 cites W2951416494 @default.
• W3211804865 cites W2952358880 @default.
• W3211804865 cites W2971809885 @default.
• W3211804865 cites W2999417355 @default.
• W3211804865 cites W3009963727 @default.
• W3211804865 cites W302653195 @default.
• W3211804865 cites W4211233744 @default.
• W3211804865 doi "https://doi.org/10.3892/mmr.2021.12533" @default.
• W3211804865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34791506" @default.
• W3211804865 hasPublicationYear "2021" @default.
• W3211804865 type Work @default.
• W3211804865 sameAs 3211804865 @default.
• W3211804865 citedByCount "4" @default.
• W3211804865 countsByYear W32118048652022 @default.
• W3211804865 countsByYear W32118048652023 @default.
• W3211804865 crossrefType "journal-article" @default.
• W3211804865 hasAuthorship W3211804865A5002294781 @default.
• W3211804865 hasAuthorship W3211804865A5007923055 @default.
• W3211804865 hasAuthorship W3211804865A5022810915 @default.
• W3211804865 hasAuthorship W3211804865A5025224262 @default.
• W3211804865 hasAuthorship W3211804865A5043860673 @default.
• W3211804865 hasAuthorship W3211804865A5057022966 @default.
• W3211804865 hasAuthorship W3211804865A5059859222 @default.
• W3211804865 hasAuthorship W3211804865A5060097504 @default.
• W3211804865 hasAuthorship W3211804865A5065196461 @default.
• W3211804865 hasBestOaLocation W32118048651 @default.
• W3211804865 hasConcept C104317684 @default.
• W3211804865 hasConcept C121608353 @default.
• W3211804865 hasConcept C137738243 @default.
• W3211804865 hasConcept C1491633281 @default.
• W3211804865 hasConcept C153911025 @default.
• W3211804865 hasConcept C2776438761 @default.
• W3211804865 hasConcept C2779723316 @default.
• W3211804865 hasConcept C2780192828 @default.
• W3211804865 hasConcept C2781018059 @default.
• W3211804865 hasConcept C29537977 @default.
• W3211804865 hasConcept C502942594 @default.
• W3211804865 hasConcept C54355233 @default.
• W3211804865 hasConcept C553184892 @default.
• W3211804865 hasConcept C55493867 @default.
• W3211804865 hasConcept C62112901 @default.
• W3211804865 hasConcept C62478195 @default.
• W3211804865 hasConcept C75217442 @default.
• W3211804865 hasConcept C85265743 @default.
• W3211804865 hasConcept C86554907 @default.
• W3211804865 hasConcept C86803240 @default.
• W3211804865 hasConcept C95444343 @default.
• W3211804865 hasConceptScore W3211804865C104317684 @default.
• W3211804865 hasConceptScore W3211804865C121608353 @default.
• W3211804865 hasConceptScore W3211804865C137738243 @default.
• W3211804865 hasConceptScore W3211804865C1491633281 @default.
• W3211804865 hasConceptScore W3211804865C153911025 @default.
• W3211804865 hasConceptScore W3211804865C2776438761 @default.
• W3211804865 hasConceptScore W3211804865C2779723316 @default.
• W3211804865 hasConceptScore W3211804865C2780192828 @default.
• W3211804865 hasConceptScore W3211804865C2781018059 @default.

• next